Shah M, Weinberger M
Department of Internal Medicine/Pediatrics, Tulane University School of Medicine, New Orleans, La., USA.
J La State Med Soc. 1998 Nov;150(11):533-7.
The purpose of this article is to acknowledge the success of using intravenous immunoglobulins in children with Guillain-Barré syndrome and to review the literature. A 17-year-old African-American young lady with Guillain-Barré syndrome of 11-days duration underwent intravenous immunoglobulin treatment. Within 6 days, the patient was ambulating and was showing significant signs of improvement. The use of intravenous immunoglobulins in children with Guillain-Barré syndrome has been reported in only a few instances.
本文旨在肯定在吉兰-巴雷综合征患儿中使用静脉注射免疫球蛋白的成效并对相关文献进行综述。一名患有持续11天吉兰-巴雷综合征的17岁非裔美国年轻女性接受了静脉注射免疫球蛋白治疗。在6天内，该患者能够行走并表现出明显的改善迹象。仅有少数病例报道了在吉兰-巴雷综合征患儿中使用静脉注射免疫球蛋白的情况。
